Cargando…
Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer
Esophageal cancer is one of the most common type of malignancies. Telomerase activity, which is absent or weakly detected in the majority of human somatic cells, is elevated in esophageal cancer. Although azidothymidine (AZT), a reverse transcriptase inhibitor, has been utilized as a treatment for t...
Autores principales: | Wang, Haoli, Zhou, Jianwen, He, Qiong, Dong, Yu, Liu, Yanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436214/ https://www.ncbi.nlm.nih.gov/pubmed/28487971 http://dx.doi.org/10.3892/mmr.2017.6549 |
Ejemplares similares
-
Effects of Treatment with Platinum Azidothymidine and Azidothymidine on Telomerase Activity and Bcl-2 Concentration in Hepatocellular Carcinoma- Induced Rats
por: Sabokrouh, Abdolreza, et al.
Publicado: (2014) -
Comparison between Platinum-Azidothymidine and Azidothymidine Effects on Bcl-2 and Telomerase Gene Expression in Rats with Hepatocellular Carcinoma
por: Sabokrouh, Abdolreza, et al.
Publicado: (2015) -
Azidothymidine
“Clicked” into 1,2,3-Triazoles:
First Report on Carbonic Anhydrase–Telomerase Dual-Hybrid Inhibitors
por: Berrino, Emanuela, et al.
Publicado: (2020) -
Azidothymidine Downregulates Insulin-Like Growth Factor-1 Induced Lipogenesis by Suppressing Mitochondrial Biogenesis and Mitophagy in Immortalized Human Sebocytes
por: Yoo, Jin Gwi, et al.
Publicado: (2021) -
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
por: Maciejewska, Natalia, et al.
Publicado: (2022)